ClowesAW, ReidyMA. Prevention of stenosis after vascular reconstruction: pharmacological control of intimal hyperplasia — a review. J Vasc Surg1991; 13: 885–91.
3.
HealyDA, ZierlerRE, NichollsSCLong-term follow-up and clinical outcome of carotid restenosis. J Vasc Surg1989; 10: 662–9.
4.
FanelliC, AronoffR.Restenosis following coronary angioplasty. Am Heart J1990; 119: 357–68.
SwedbergSH, BrownBG, SigleyR, WightTN, GordonD, NichollsSC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: clinical immunocytochemical, light and electron microscopic assessment. Circulation1989; 80: 1726–36.
7.
RekhterM, NichollsS, FergusonM, GordonD.Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb1993; 13: 609–17.
8.
ClagettGP, RobinowitzM, YoukeyJRMorphogenesis and clinicopathologic characteristics of recurrent carotid disease. J Vasc Surg1986; 3: 10–23.
9.
O'BrienER, AlpersCE, StewardDKProliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res1993; 73: 223–31.
10.
CarrelA, GuthrieCC. Results of the biterminal transplantation of veins. Am J Med Sci1906; 132: 415–22.
11.
FloreyHW, GreerSJ, KiserJ, PooleJCF, TelanderR, WerthessenNT. The development of the pseudointima lining fabric grafts of the aorta. Br J Exp Pathol1962; 43: 655–60.
12.
BaumgartnerHR, StuderA.Consequences of vessel catheterization in normal and hypercholesterolemic rabbits. Pathol Microbiol1966; 29: 393–405.
13.
ClowesAW, ReidyMA, ClowesMM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest1983; 49: 327–33.
14.
ClowesAW, ReidyMA, ClowesMM. Mechanisms of stenosis after arterial injury. Lab Invest1983; 49: 208–15.
15.
MianoJM, VlasicN, TotaRR, StemermanMB. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: a putative in vivo mechanism for autocrine growth. Arterioscler Thromb1993; 13: 211–19.
16.
MarmurJD, PoonM, RossikhinaM, TaubmanMB. Induction of PDGF-responsive genes in vascular smooth muscle: implications for the early response to vessel injury. Circulation1992; 86(Suppl): 53–60.
17.
MajeskyM, ReidyM, BendittEP, SchwartzS.Expression of platelet-derived growth factor (PDGF) A- and B-chain gene in smooth muscle during repair of arterial injury. J Mol Cell Cardiol1987; 19(Suppl IV): S3.
18.
MajeskyMW, ReidyMA, Bowen-PopeDF, HartCE, WilcoxJN, SchwartzSM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol1990; 111: 2149–58.
19.
ReidyMA. Endothelial regeneration. VIII. Interaction of smooth muscle cells with endothelial regrowth. Lab Invest1988; 59: 36–43.
20.
ReidyMA, ClowesAW, SchwartzSM. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest1983; 49: 569–75.
21.
ReidyMA, ChaoSS, KirkmanTR, ClowesAW. Endothelial regeneration. VI. Chronic nondenuding injury in baboon vascular grafts. Am J Pathol1986; 123: 432–9.
22.
BergerK, SauvageLR, RaoAM, WoodSJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg1972; 175: 118–27.
23.
ClowesAW, CollazzoRE, KarnovskyMJ. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest1978; 39: 141–50.
24.
ZachariasRK, KirkmanTR, ClowesAW. Mechanisms of healing in synthetic grafts. J Vasc Surg1987; 6: 429–36.
KohlerTR, JawienA.Flow affects development of intimal hyperplasia after arterial injury in rats. Arterioscler Thromb1992; 12: 963–71.
27.
WilcoxJN, SmithKM, SchwartzSM, GordonD.Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U SA1989; 86: 2839–43.
28.
SchneidermanJ, SawdeyMS, KeetonMRIncreased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA1992; 89: 6998–7002.
29.
DawsonS, HenneyA.The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis1992; 95: 105–17.
30.
GordonD, ReidyMA, BendittEP, SchwartzSM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A1990; 87: 4600–4.
31.
RossR.The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature1993; 362: 801–9.
32.
FriedmanRJ, StemermanMB, WenzBThe effect of thrombocytopenia on experimental atherosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and reendothelialization. J Clin Invest1977; 60: 1191–201.
33.
FingerleJ, JohnsonR, ClowesAW, MajeskyMW, ReidyMA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA1989; 86: 8412–16.
34.
RainesEW, RossR.Platelet-derived growth factor in vivo. Cytokines1993; 5: 74–114.
35.
JawienA, Bowen-PopeDF, LindnerV, SchwartzSM, ClowesAW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest1992; 89: 507–11.
36.
FernsGAA, RainesEW, SprugelKH, MotaniAS, ReidyMA, RossR.Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science1991; 253: 1129–32.
37.
ReidyMA, FingerleJ, LindnerV.Factors controlling the development of arterial lesions after injury. Circulation1992; 86(Suppl): 43–6.
38.
ReidyMA. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Thromb Haemost1993; 70: 172–6.
39.
DaemenMJAP, LombardiDM, BosmanFT, SchwartzSM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res1991; 68: 450–6.
40.
MajeskyMW, LindnerV, TwardzikDR, SchwartzSM, ReidyMA. Production of transforming growth factor β during repair of arterial injury. J Clin Invest1991; 88: 904–10.
41.
CercekB, FishbeinMC, ForresterJS, HelfantRH, FaginJA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res1990; 66: 1755–60.
42.
Scott-BurdenT, VanhouttePM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation1993; 87(Suppl 5): V51–5.
43.
HanssonGK, JonassonL, HolmJ, ClowesMM, ClowesAW. Gamma interferon regulates vascular smooth muscle proliferation and la expression in vitro and in vivo. Circ Res1988; 63: 712–19.
44.
LibbyP, HanssonGK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest1991; 64: 5–15.
45.
ClowesAW. The role of aspirin in enhancing arterial graft patency. J Vasc Surg1986; 3: 381–5.
SchwartzL, LesperanceJ, BourassaMGThe role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. Am Heart J1990; 119: 232–6.
48.
ClowesAW. Heparin: will it control intimal thickening after angioplasty?Circulation1992; 86: 1657–8.
49.
MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation1992; 86: 100–10.
50.
HeyndrickxGR, MERCATOR. Angiotensin-converting enzyme inhibitor in a human model of restenosis. Basic Res Cardiol1993; 88(Suppl. 1): 169–82.
51.
PowellJS, ClozelJP, MullerRKMInhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science1989; 245: 186–8.
52.
PrescottMF, WebbRL, ReidyMA. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol1991; 139: 1291–6.
53.
FarhyRD, CarreteroOA, HoK-L, ScicliAG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res1993; 72: 1202–10.
54.
O'DonohoeMK, SchwartzLB, RadicZS, MikatEM, McCannRL, HagenP-O. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg1991; 214: 727–32.
55.
HuberKC, SchwartzRS, EdwardsWDEffects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Ant Heart J1993; 125: 695–701.
56.
ChurchillDA, SiegelCO, MinorST, WestMS, RaiznerAE. Enalapril in the prevention of restenosis following intracoronary intervention in a swine model. Coronary Artery Dis1993; 4: 461–7.
57.
HansonSR, PowellJS, DodsonTEffects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension1991; 18(Suppl): II70–6.
58.
FerrellM, FusterV, GoldHK, ChesebroJH. A dilemma for the 1990s: choosing appropriate experimental animal models for the prevention of restenosis. Circulation1992; 85: 1630–1.
59.
AuYPT, KenagyRD, ClowesMM, ClowesAW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis1993; 23(Suppl. 1): 177–82.
60.
ChanP, PatelM, BetteridgeLAbnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis. Lancet1993; 341: 341–2.
LemarchandP, JonesM, YamadaI, CrystalRG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res1993; 72: 1132–8.
63.
LynchCM, ClowesMM, OsborneWRA, ClowesAW, MillerAD. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci USA1992; 89: 1138–42.
